-
OPPORTUNITIES AND BARRIERS TO INTEGRATING REAL-WORLD EVIDENCE IN US PAYER DECISION MAKING
Feb 25, 2026, 14:40 PM -
CARBON AVOIDANCE: A COMPARISON OF SURGICAL APPROACHES
Feb 25, 2026, 14:40 PM -
NETNOGRAPHY AS A QUALITATIVE RESEARCH APPROACH TO SUPPORT PATIENT-REPORTED OUTCOME AND PATIENT PREFERENCE RESEARCH IN HEOR
Feb 25, 2026, 14:40 PM -
PEMBROLIZUMAB ALONE VERSUS CHEMO-IMMUNOTHERAPY IN METASTATIC NSCLC: A 2024 MEDICARE-BASED MARKOV COST-EFFECTIVENESS ANALYSIS
Feb 25, 2026, 14:40 PM -
COMPARING SELF-CONTROLLED CASE SERIES AND COHORT DESIGNS FOR ESTIMATING PANCREATITIS RISK ASSOCIATED WITH GLP-1 RECEPTOR AGONISTS: A MONTE CARLO SIMULATION STUDY
Feb 25, 2026, 14:40 PM -
FROM INCORPORATION TO IMPACT: REAL-WORLD BUDGET ADVANTAGE OF CLADRIBINE IN MULTIPLE SCLEROSIS WITHIN A BRAZILIAN PRIVATE HEALTH PLAN
Feb 25, 2026, 14:40 PM -
GLOBAL AND REGIONAL ESTIMATES OF CLINICAL AND ECONOMIC BURDEN OF OSTEOARTHRITIS IN LOW- AND MIDDLE-INCOME COUNTRIES: A SYSTEMATIC REVIEW
Feb 25, 2026, 14:40 PM -
SELF-REPORTED MARIJUANA USE, PAIN LEVELS, AND OPIOID USE AMONG ADULT CANCER SURVIVORS IN ARKANSAS
Feb 25, 2026, 14:40 PM -
BEYOND SURVIVAL: HOW NON-HODGKIN LYMPHOMA IMPACTS WELL-BEING AND FINANCES COMPARED TO OTHER CANCERS
Feb 25, 2026, 14:40 PM -
CLINICAL UNMET NEEDS AND NON-INVASIVE TREATMENT PREFERENCES IN HISL MANAGEMENT: A MIXED-METHODS STUDY IN CHINA
Feb 25, 2026, 14:40 PM -
OPTIMIZING ACCESS TO ACORAMIDIS IN THE UNITED STATES: THE ROLE OF PATIENT ACCESS LIAISONS (PALS) IN TRANSTHYRETIN AMYLOID CARDIOMYOPATHY (ATTR-CM)
Feb 25, 2026, 14:40 PM -
INCIDENCE OF IMMUNE CHECKPOINT INHIBITOR-ASSOCIATED PNEUMONITIS AMONG NON-SMALL CELL LUNG CANCER PATIENTS WITH AND WITHOUT PRE-EXISTING COPD
Feb 25, 2026, 14:40 PM -
UTILIZATION OF TARLATAMAB AND ASSOCIATED HEALTHCARE RESOURCE USE, COSTS, AND ADVERSE EVENTS: A RETROSPECTIVE COHORT STUDY USING A LARGE U.S. HOSPITAL DATABASE
Feb 25, 2026, 14:40 PM -
POPULATION CHARACTERISTICS AND CLINICAL MEDICATION PATTERNS OF COUGH PATIENTS IN CHINA BASED ON REGIONAL REAL-WORLDDATA
Feb 25, 2026, 14:40 PM -
ADOPTION AS A MISSING LINK IN HEOR: EVIDENCE MAPPING OF HEALTHCARE INNOVATION UPTAKE
Feb 25, 2026, 14:40 PM -
ECONOMIC SAVINGS FROM A RATIONAL IMMUNOGLOBULIN USE STRATEGY IN PATIENTS WITH PRIMARY IMMUNODEFICIENCIES
Feb 25, 2026, 14:40 PM -
ESTIMATION OF FAIRNESS OF DISTRIBUTION OF HUNGARIAN HOSPITAL BEDS BY CALCULATING GINI COEFFICIENT
Feb 25, 2026, 14:40 PM -
THE ROLE OF SAFETY AND TOLERABILITY IN HTA VALUE ASSESSMENT: EVIDENCE REQUIREMENTS AND IMPACT ACROSS KEY EUROPEAN MARKETS
Feb 25, 2026, 14:40 PM -
THE BLUES CLOUD THE VIEW: PROXY DEPRESSION IS ASSOCIATED WITH LOWER DYADIC AGREEMENT ON EQ-5D-5L
Feb 25, 2026, 14:40 PM -
ECONOMIC IMPACT OF DELAYED ACCESS TO FINERENONE DUE TO FORMULARY RESTRICTIONS IN CHRONIC KIDNEY DISEASE (CKD) AND TYPE 2 DIABETES (T2D)
Feb 25, 2026, 14:40 PM
